Star Combo Pharma Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	5.25	0.75	-4	-0.7	-7.88
Depreciation & Amortization	1.89	1.06	0.51	0.66	0.67
Other Amortization	0.01	0.01	0.01	0.16	0.16
Loss (Gain) From Sale of Assets	-	-	0	0.09	-
Asset Writedown & Restructuring Costs	-	-	4.41	1.46	6.34
Stock-Based Compensation	-	-	-	0.01	-
Provision & Write-off of Bad Debts	-	0.1	0.03	-0.01	0.27
Other Operating Activities	0.2	-0.16	-0.2	-0.1	-0.85
Change in Accounts Receivable	2.1	-0.18	-1.15	-0.29	-0.29
Change in Inventory	1.37	-2.14	1.17	-0.87	0.88
Change in Accounts Payable	1.12	0.17	0.29	0.45	0.3
Change in Income Taxes	-0.23	-	-	0.04	0.13
Change in Other Net Operating Assets	-0.07	0.05	0.07	0.05	0.19
Operating Cash Flow	11.94	-0.32	1.88	0.53	0.33
Operating Cash Flow Growth	-	-	251.52%	61.04%	-
Capital Expenditures	-0.39	-1.44	-2.73	-7.29	-7.26
Cash Acquisitions	-	-	-	-	-0.27
Sale (Purchase) of Intangibles	-	-	-0	-	-
Investment in Securities	-9.33	1.31	-0.5	4.05	9.95
Other Investing Activities	-	-	-0	-	-
Investing Cash Flow	-9.72	-0.14	-3.23	-3.24	2.42
Long-Term Debt Issued	0.05	-	0.14	-	-
Total Debt Issued	0.05	-	0.14	-	-
Long-Term Debt Repaid	-0.14	-0.16	-0.07	-0.17	-2.08
Net Debt Issued (Repaid)	-0.09	-0.16	0.07	-0.17	-2.08
Issuance of Common Stock	-	-	0.08	-	-
Common Dividends Paid	-0.5	-	-	-	-
Other Financing Activities	-0.2	-0.21	-0.2	-	-
Financing Cash Flow	-0.8	-0.37	-0.05	-0.17	-2.08
Net Cash Flow	1.43	-0.82	-1.41	-2.88	0.67
Free Cash Flow	11.55	-1.76	-0.85	-6.76	-6.93
Free Cash Flow Margin	41.52%	-6.76%	-3.44%	-29.45%	-25.68%
Free Cash Flow Per Share	0.09	-0.01	-0.01	-0.05	-0.05
Cash Interest Paid	0.37	0.38	0.37	0.22	0.26
Cash Income Tax Paid	-	-	-0.18	-	-0.13
Levered Free Cash Flow	8.79	-1.74	-1.22	-5.73	-8.8
Unlevered Free Cash Flow	8.91	-1.62	-1.11	-5.62	-8.65
Change in Working Capital	4.59	-2.08	1.11	-1.04	1.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.